Literature DB >> 12421894

Clinical practice. Nondiabetic kidney disease.

Andrew S Levey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12421894     DOI： 10.1056/NEJMcp013462

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry disease.

Authors:  Raphael Schiffmann; Caren Swift; Xuan Wang; Derek Blankenship; Markus Ries
Journal:  J Inherit Metab Dis       Date:  2015-04-22       Impact factor: 4.982

2.  Left atrial size and risk for all-cause mortality and ischemic stroke.

Authors:  Alberto Bouzas-Mosquera; Francisco J Broullón; Nemesio Álvarez-García; Elizabet Méndez; Jesús Peteiro; Teresa Gándara-Sambade; Oscar Prada; Víctor X Mosquera; Alfonso Castro-Beiras
Journal:  CMAJ       Date:  2011-05-24       Impact factor: 8.262

3.  Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing.

Authors:  Raphael Schiffmann; Hasan Askari; Margaret Timmons; Chevalia Robinson; William Benko; Roscoe O Brady; Markus Ries
Journal:  J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 10.121

4.  Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease.

Authors:  Manal F Elshamaa; Samar M Sabry; Hafez M Bazaraa; Hala M Koura; Eman A Elghoroury; Nagwa A Kantoush; Eman H Thabet; Dalia A Abd-El Haleem
Journal:  J Inflamm (Lond)       Date:  2011-08-23       Impact factor: 4.981

5.  Care of elderly patients with chronic kidney disease.

Authors:  Pradeep Arora; Reem A Mustafa; Jyotheen Karam; Patricia Khalil; Greg Wilding; Rajiv Ranjan; James Lohr
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

6.  Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention.

Authors:  C Mueller; F-J Neumann; A P Perruchoud; H J Buettner
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

7.  Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation.

Authors:  Tobias Reichlin; Stephen J Lockwood; Michael J Conrad; Eyal Nof; Gregory F Michaud; Roy M John; Laurence M Epstein; William G Stevenson; Petr Jarolim
Journal:  J Interv Card Electrophysiol       Date:  2016-03-12       Impact factor: 1.900

8.  Agalsidase alfa and kidney dysfunction in Fabry disease.

Authors:  Michael West; Kathy Nicholls; Atul Mehta; Joe T R Clarke; Robert Steiner; Michael Beck; Bruce A Barshop; William Rhead; Robert Mensah; Markus Ries; Raphael Schiffmann
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

Review 9.  Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.

Authors:  Wan-Chuan Tsai; Hon-Yen Wu; Yu-Sen Peng; Ju-Yeh Yang; Hung-Yuan Chen; Yen-Ling Chiu; Shih-Ping Hsu; Mei-Ju Ko; Mei-Fen Pai; Yu-Kang Tu; Kuan-Yu Hung; Kuo-Liong Chien
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

Review 10.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Authors:  Caroline S Fox; Kunihiro Matsushita; Mark Woodward; Henk J G Bilo; John Chalmers; Hiddo J Lambers Heerspink; Brian J Lee; Robert M Perkins; Peter Rossing; Toshimi Sairenchi; Marcello Tonelli; Joseph A Vassalotti; Kazumasa Yamagishi; Josef Coresh; Paul E de Jong; Chi-Pang Wen; Robert G Nelson
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.